About 328 results

ALLMedicine™ Acquired Von Willebrand Syndrome Center

Research & Reviews  126 results

Individual Variability in von Willebrand Factor Fragility in Response to Shear Stress: ...
ASAIO Journal (American Society for Artificial Internal O... Sakatsume K, Akiyama M et. al.

Dec 31st, 2021 - Acquired von Willebrand syndrome (AVWS), characterized by reduced von Willebrand factor (VWF) large multimers, has recently been implicated as the principal mechanism underlying bleeding in patients implanted with left ventricular assist devices (...

In Vitro Comparison of Recombinant and Plasma-Derived von Willebrand Factor Concentrate...
Anesthesia and Analgesia; Mazzeffi M, Henderson R et. al.

Dec 15th, 2021 - Coagulopathic bleeding is common during adult extracorporeal membrane oxygenation (ECMO), and acquired von Willebrand syndrome is a contributing factor. We compared ECMO patient blood samples that were treated in vitro with recombinant von Willebr...

Thrombocytapheresis for acquired von Willebrand syndrome in a patient with essential th...
Transfusion Oyedeji O, Sheqwara J et. al.

Sep 28th, 2021 - Essential thrombocythemia (ET) is associated with increased risk of bleeding secondary to acquired von Willebrand syndrome (AVWS). Bleeding in ET requires urgent platelet reduction by cytoreductive therapy such as hydroxyurea or thrombocytapheresi...

Acquired von Willebrand Syndrome.
Hematology/oncology Clinics of North America; Langer AL, Connell NT

Aug 16th, 2021 - Acquired von Willebrand syndrome can occur in the setting of myeloproliferative neoplasms; plasma cell dyscrasias and other lymphoproliferative disorders; autoimmune conditions; and causes of increased shear forces, such as aortic stenosis or othe...

Perspectives on Heyde's Syndrome and Calcific Aortic Valve Disease.
Current Problems in Cardiology; Abdelmaseih R, Thakker R et. al.

Aug 14th, 2021 - Heyde's syndrome is a multisystem disorder describing the association between calcified aortic stenosis, gastrointestinal tract bleeding from arteriovenous malformations, and acquired von Willebrand syndrome. Several studies have reported an incre...

see more →

Guidelines  2 results

Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHL...
American Journal of Hematology; Nichols WL, Rick ME et. al.

May 6th, 2009 - Von Willebrand factor (VWF) mediates blood platelet adhesion and accumulation at sites of blood vessel injury, and also carries coagulation factor VIII (FVIII) that is important for generating procoagulant activity. Von Willebrand disease (VWD), t...

von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the N...
Haemophilia : the Official Journal of the World Federatio... Nichols WL, Hultin MB et. al.

Mar 5th, 2008 - von Willebrand disease (VWD) is a commonly encountered inherited bleeding disorder affecting both males and females, causing mucous membrane and skin bleeding symptoms, and bleeding with surgical or other haemostatic challenges. VWD may be disprop...

see more →

Clinicaltrials.gov  1 results

Acquired Von Willebrand Syndrome in Severe Aortic Stenosis

Sep 30th, 2011 - Patients with severe aortic stenosis often suffer from an acquired Von Willebrand syndrome by degeneration of the polymers during passage through the narrow valve leading to turbulences. After written consent and an extended anamnesis of existing ...

see more →

News  2 results

JAK2 Mutations and JAK Inhibitors in the Management of Myeloproliferative Neoplasms

Dec 5th, 2020 - The Philadelphia chromosome—negative myeloproliferative neoplasms (MPNs) are clonal disorders characterized by common mutations, but with distinct clinical features, treatment considerations, and prognostic outlooks.1 Identification of the JAK2 (J...

Teach your adolescent patients about normal menses, so they know when it’s abnormal
Pediatric News;

Nov 6th, 2017 - Von Willebrand syndrome Von Willebrand syndrome is a deficiency or dysfunction of von Willebrand factor (vWF), a protein with binding sites for platelets, collagen, and factor VIII that “serves as a bridge between platelets and injury sites in ves.

see more →